Cica Complex provides soothing relief by calming irritation
The 78-week PIONEER-3 study compared 1864 adults with diagnosed type-2 diabetes who received either metformin (with or without sulfonylurea), oral semaglutide in three different dosages, or sitagliptin (100 mg/d)
Tirzepatide Tirzepatide is a newer medication that works as a dual GIP/GLP-1 receptor agonist, targeting two hormones involved in appetite and blood sugar regulation
Its safety, efficacy, and pharmacological profile in humans have not been established
Final results, once swelling fully resolves, can take several months to appear, depending on the procedures performed
The drug is not the enemy